Gene therapy of chondrosarcoma using retrovirus vectors encoding the herpes simplex virus thymidine kinase gene

Citation
M. Seto et al., Gene therapy of chondrosarcoma using retrovirus vectors encoding the herpes simplex virus thymidine kinase gene, INT J ONCOL, 14(6), 1999, pp. 1137-1141
Citations number
18
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
INTERNATIONAL JOURNAL OF ONCOLOGY
ISSN journal
10196439 → ACNP
Volume
14
Issue
6
Year of publication
1999
Pages
1137 - 1141
Database
ISI
SICI code
1019-6439(199906)14:6<1137:GTOCUR>2.0.ZU;2-S
Abstract
Human chondrosarcoma cells (HCS-TG) were transduced with the gene for a her pes simplex virus thymidine kinase (HSV-tk) or Escherichia coli beta-galact osidase (lacZ). We investigated the cytotoxicity of human chondrosarcoma be aring an HSV-tk gene after treatment with ganciclovir. Chondrosarcoma cells bearing an HSV-tk gene were more sensitive than non-transduced cells. Cocu lturing with chondrosarcoma cells bearing both an HSV-tk gene (HCS-TG-tk) a nd lacZ gene (HCS-TG-Z) in various ratios showed a bystander effect. Chondr osarcoma implanted in nude mice were injected with HCS-TG-tk cells. After 4 weeks, the growth of tumors was significantly prevented.